| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/16/2006 | US20060035213 POSH nucleic acids, polypeptides and related methods |
| 02/16/2006 | US20060035209 Screening method |
| 02/16/2006 | US20060034943 Inducing apoptosis in cancer cells; administering cell cycle arresting drug, microtubules and stabilizing agent then exposing to vibrational energy |
| 02/16/2006 | US20060034869 Drug for treating liver diseases with the use of hollow protein nanoparticles |
| 02/16/2006 | US20060034863 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 02/16/2006 | US20060034852 Comprising transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor moiety and an immunoglobulin moiety comprising a heavy chain constant region of an immunoglobulin; interfere with binding of a tumor necrosis factor receptor with its ligand; antitumor agents |
| 02/16/2006 | US20060034843 Interaction of Smad6 with Hox proteins and uses thereof |
| 02/16/2006 | US20060034834 Intrabody-mediated control of immune reactions |
| 02/16/2006 | US20060034817 Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase |
| 02/16/2006 | US20060034813 Expression of proteins in cord blood-derived endothelial cells |
| 02/16/2006 | US20060034812 Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect |
| 02/16/2006 | US20060034811 Melanoma vaccine and methods of making and using same |
| 02/16/2006 | US20060034810 Novel artificial antigen presenting cells and uses therefor |
| 02/16/2006 | US20060034805 adeno-associated virus (AAV) vector for expression of a recombinant immunoglobulin; comprises self-processing cleavage site comprises a 2A sequence e.g. a Foot and Mouth Disease Virus (FMDV) sequence; cancer; treatment and prevention of infectious and autoimmune disease |
| 02/16/2006 | US20060034804 Adenoviral vectors having a protein IX deletion |
| 02/16/2006 | US20060034803 Therapeutic device for osteogenesis |
| 02/16/2006 | US20060034764 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/16/2006 | DE102004035227A1 mRNA-Gemisch zur Vakzinierung gegen Tumorerkrankungen mRNA mixture for vaccination against tumors |
| 02/16/2006 | CA2578478A1 Product and process for inhibition of biofilm development |
| 02/16/2006 | CA2576923A1 Vector |
| 02/16/2006 | CA2576573A1 Use of pax4 in pancreatic cell proliferation |
| 02/16/2006 | CA2576280A1 Helicobacter pylori-based delivery system |
| 02/16/2006 | CA2576193A1 Taj in neuronal function |
| 02/16/2006 | CA2572326A1 Capsules containing transfected cells, method for preparing the same and uses thereof for immunization and vaccination |
| 02/16/2006 | CA2571955A1 Methods for treating cancer using agents that inhibit wnt16 signaling |
| 02/15/2006 | EP1626096A2 In vitro method of detecting a cell proliferative disorder involving fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/15/2006 | EP1626091A2 Duplexed parvovirus vectors |
| 02/15/2006 | EP1626090A1 Novel virus vector |
| 02/15/2006 | EP1626084A1 Compositions and methods for the diagnosis of tumours |
| 02/15/2006 | EP1626083A1 Substances for preventing and treating autoimmune diseases |
| 02/15/2006 | EP1626058A1 Compositions and methods for the diagnosis of tumour |
| 02/15/2006 | EP1625858A1 Compounds for treating ischemic tissue |
| 02/15/2006 | EP1625395A1 Method for identifying tff2 regulating agents and agents identified using said method |
| 02/15/2006 | EP1625222A2 Broadening adenovirus tropism |
| 02/15/2006 | EP1625220A2 An autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells |
| 02/15/2006 | EP1625206A2 siRNA INDUCED SYSTEMIC GENE SILENCING IN MAMMALIAN SYSTEMS |
| 02/15/2006 | EP1625149A2 Method and carrier complexes for delivering molecules to cells |
| 02/15/2006 | EP1625148A1 Peptide complex |
| 02/15/2006 | EP1625142A2 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 02/15/2006 | EP1625141A2 Grp94-based compositions and methods of use thereof |
| 02/15/2006 | EP1625140A2 Branched immunomodulatory compounds and methods of using the same |
| 02/15/2006 | EP1624899A2 Increased transduction using abc transporter substrates and/or inhibitors |
| 02/15/2006 | EP1624898A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 02/15/2006 | EP1624889A2 Compositions for inducing immune responses |
| 02/15/2006 | EP1624758A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 02/15/2006 | EP1578802A4 Dna/rna transduction technology and its clinical and basic applications |
| 02/15/2006 | EP0946741B1 Method for producing recombinant virus |
| 02/15/2006 | EP0840794B1 Medicament containing at least one part of the ul84 protein of the cytomegalovirus, use of polypeptides corresponding to the amino acid sequence of the ul84 protein, and process for introducing ul84 into target cells |
| 02/15/2006 | EP0795021B1 Retroviral delivery of full length factor viii |
| 02/15/2006 | EP0791050B1 Vectors for tissue-specific replication |
| 02/15/2006 | CN1735628A Polypeptides F' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
| 02/15/2006 | CN1735427A Pain relief agents |
| 02/15/2006 | CN1733916A siRNA for suppressing Stat3 gene expression and its preparation method |
| 02/15/2006 | CN1733911A Recombinant virus containing BPI gene and pharmaceutical composition containing same and uses |
| 02/15/2006 | CN1733314A Process for preparing cerebrose albumin magnetic adriamycin nanometer particle |
| 02/15/2006 | CN1733313A Process for preparing poly n-butyl cyan acrylate nanometer particle |
| 02/15/2006 | CN1733309A Process for preparing driving target-directional carrier of folic acid compound mediated |
| 02/15/2006 | CN1242065C Pig breeding and respiratory syndrome recombinant adenovirus and vaccine |
| 02/15/2006 | CN1242063C PGO of RNA1 carrier possessing labelling of green fluorescence protein and screening tag of resistance |
| 02/15/2006 | CN1241646C Improvement in or relating to endometrial function |
| 02/15/2006 | CN1241643C Novel pestilence DNA vaccine and its construction and application |
| 02/15/2006 | CN1241642C Novel pestilence DNA vaccine and its usage |
| 02/15/2006 | CN1241549C Amphoteric liposomes and the use thereof |
| 02/14/2006 | US6998474 used for prevention and/or treatment of pathologies, dysfunctions, disorders or conditions affecting the nervous system |
| 02/14/2006 | US6998268 Gene preparations |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | US6998244 contacting a cell transformed or transfected with an expression vector capable of expressing 5-HT4 receptor with a compound in presence of a ligand, monitoring CAMP formation in the cell, a change indicates compund as an antagonist or agonist |
| 02/14/2006 | US6998238 Method for determining MIF content |
| 02/14/2006 | US6998118 Transducing neuron with gene; Alzheimer's disease, Parkinson's disease, amyotropic lateral sclerosis |
| 02/14/2006 | US6998117 Cancer treatment with retroviral vectors comprising wild-type p53 |
| 02/14/2006 | US6998115 Biodegradable and biocompatible and may be used in a variety of drug delivery systems; suited for the delivery of polynucleotides |
| 02/14/2006 | CA2269072C Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/09/2006 | WO2006015389A2 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 02/09/2006 | WO2006015127A2 Treating cardiovascular tissue |
| 02/09/2006 | WO2006014798A2 Methods and compositions for using sax2 |
| 02/09/2006 | WO2006014737A2 Growth hormone releasing hormone enhances the immune response induced by vaccination |
| 02/09/2006 | WO2006014551A2 In vivo methods for effecting tissue specific differentiation of embryonic stem cells |
| 02/09/2006 | WO2006014234A2 Novel recombinant poxvirus composition and uses thereof |
| 02/09/2006 | WO2006014159A2 Methods of using regenerative cells in the treatment of musculoskeletal disorders |
| 02/09/2006 | WO2006013904A1 Medicinal composition containing meltrin antagonist |
| 02/09/2006 | WO2006013457A2 Gad2 gene for possible treatment of nervous system disorders |
| 02/09/2006 | WO2006013013A2 Diagnostics and therapeutics for diseases associated with protective protein for beta-galactosidase (ppgb) |
| 02/09/2006 | WO2005113786A3 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 02/09/2006 | WO2005110479A3 Treatments for pancreatic cancer |
| 02/09/2006 | WO2005086896A3 Delivery vectors for short interfering rna, micro-rna and antisense rna |
| 02/09/2006 | WO2004113517A3 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| 02/09/2006 | WO2003105761A3 Immunotoxin as a therapeutic agent and uses thereof |
| 02/09/2006 | US20060031956 Nucleotide sequences for gene regulation and methods of use thereof |
| 02/09/2006 | US20060031951 Improved modalities for the treatment of degenerative diseases of the retina |
| 02/09/2006 | US20060031946 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 02/09/2006 | US20060030694 Antitumor agents; fusion protien increases biological half life |
| 02/09/2006 | US20060030541 Genes involved in osteogenesis, and methods of use |
| 02/09/2006 | US20060030540 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 02/09/2006 | US20060030539 Administering a mixture of a first compound that inhibits the polymerization of actin microfilaments or depolymerizes actin microfilaments and an anti-DNA compound; cystic fibrosis; Legionnaire's Disease; medical device-related infections, implant infections |
| 02/09/2006 | US20060030538 Methods for reducing or preventing localized fibrosis using SiRNA |
| 02/09/2006 | US20060030537 Ceramide kinase and uses thereof |
| 02/09/2006 | US20060030536 Combination therapies for cancer and proliferative angiopathies |
| 02/09/2006 | US20060030535 Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics |
| 02/09/2006 | US20060030534 Alzheimer's, Parkinson's, multiple sclerosis, schizophrenia, epilepsy, depression and pain |